Web-Based Resources. Locating Treatment



Similar documents
Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

Opioid overdose can occur when a patient misunderstands the directions

John R. Kasich, Governor Orman Hall, Director

Increasing Access to Opioid Addiction Treatment

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN

How To Treat Anorexic Addiction With Medication Assisted Treatment

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Free Additional Resources

Prescriber Behavior, Pain Treatment and Addiction Treatment

Licensure of Substance Abuse Treatment Programs Required Amendments

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

Effective Treatment Strategies for Adolescent Heroin and Opiate Use. Chris Gleason, MA, CAADC, MAATP Director Rosecrance McHenry County

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health

TREATMENT MODALITIES. May, 2013

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

The Heroin Epidemic in Adolescents and Young Adults. Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015

Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009

National Alliance of Methadone Advocates

Performance Standards

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

1) What would it take to get four or five FQHCs to implement ECHO, and how many patients can we serve?

Practice Protocol. Buprenorphine Guidance Protocol

ARCHIVED BULLETIN. Product No L SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E

Allyse Adams PC, LICDC Oriana House, Inc.

MEDICAL POLICY Treatment of Opioid Dependence

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

NEW HAMPSHIRE CODE OF ADMINISTRATIVE RULES. PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES

State Policies and Adoption of Buprenorphine: Summary Results of Telephone Interviews with State Agency Staff

Using Buprenorphine in an Opioid Treatment Program

Use of Pharmacotherapies by Substance Abuse Treatment Facilities

Governor s Task Force on Mental Health and Substance Use.

VI. Substance Use Disorder Services

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014

Opioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015

Joel Millard, DSW, LCSW Dave Felt, LCSW

Care Management Council submission date: August Contact Information

The ABCs of Medication Assisted Treatment

Program Assistance Letter

Medicaid Behavioral Health Clinic Rehabilitation Services Manual

SUBSTANCE ABUSE OUTPATIENT

Testimony on Addressing Heroin and Opioid Addiction. Theodore Dallas. Secretary, Department of Human Services. Center for Rural Pennsylvania

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director

Various therapies are used in the

Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner. NASADAD 2015 Annual Meeting

Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to

BUPRENORPHINE TREATMENT

Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program The West Virginia Model

Treatment Approaches for Drug Addiction

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:

Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft***

Congressional Testimony. Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry

Federal Response to Opioid Abuse Epidemic

OUTPATIENT SUBSTANCE USE DISORDER SERVICES FEE-FOR-SERVICE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

Office-based Treatment of Opioid Dependence with Buprenorphine

Acronyms for the Prevention and Treatment of Substance Use Disorders. Prepared by Mental Health Legal Advisors Committee November 2015

TESTIMONY. March 17, Rutland, VT

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Medication-Assisted Treatment for Opioid Addiction

Performance Standards

Substance Use: Addressing Addiction and Emerging Issues

Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition

Treatment Approaches for Drug Addiction

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

CHAPTER 5. Rules and Regulations for Substance Abuse Standards. Special Populations for Substance Abuse Services

8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER

ARTICLE 4.4. ADDICTION TREATMENT SERVICES PROVIDER CERTIFICATION

SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

Expanding access to treatment for opiate addiction: Successes and Barriers

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

Transcription:

Web-Based Resources Locating Treatment http://dpt2.samhsa.gov/treatment/ -- This is the Substance Abuse and Mental Health Services Administration s (SAMHSA) page for locating both public and private opiate addiction treatment programs across the country. http://buprenorphine.samhsa.gov/bwns_locator/ -- SAMHSA s page for locating providers across the country who are qualified to provide treatment with Buprenorphine. http://www.naabt.org/ -- This is the National Alliance of Advocates for Buprenorphine Treatment s (NAABT) page for locating providers across the country who are certified to provide treatment with Buprenorphine. (Please keep in mind that not all providers listed on SAMHSA s locator above are listed here and physicians are not required to list themselves on either treatment locator page). http://mhmr.ky.gov/providerdirectory/onlineproviderdirectory.aspx -- This is the Kentucky Department for Behavioral Health, Developmental and Intellectual Disabilities (DBHDID) provider directory that you may use to locate various types of treatment in Kentucky such as crisis stabilization, psychiatric hospitals, DUI education providers, and licensed drug and alcohol treatment. Advocacy and Support http://lac.org/index.php/lac/category/free_publications_library -- The Legal Action Center is the only non-profit law and policy organization in the United States whose sole mission is to fight discrimination against people with histories of addiction, HIV/AIDS, or criminal records, and to advocate for sound public policies in these areas. This site provides current news, free publications, free webinars, and legal assistance resources. http://www.americainrecovery.org/ -- This is a no-charge hiring website that links employers with job seekers who may have a disability, be in recovery, have a prior criminal record, and older individuals. America in Recovery offers them a chance to find a job, to be productive again, and to build their self worth. http://www.naabt.org/ -- The National Alliance of Advocates for Buprenorphine Treatment (NAABT) is a non-profit organization with the mission to educate the public about the disease of opioid addiction and the buprenorphine treatment option, to help reduce the stigma and discrimination associated with patients with addiction disorders, and serve as a channel connecting patients in need of treatment to qualified treatment providers. This site provides a treatment locator, online support forum, educational resources, and free publications.

http://heretohelpprogram.com/default.aspx -- The Here to Help Program was created by Reckitt-Benckiser and it provides free support during Suboxone treatment including telephone access to a Care Coach, online tools and resources, and supportive emails. http://www.facesandvoicesofrecovery.org/ -- Faces & Voices of Recovery (FAVOR) is a national 501(c)(3) non-profit organization that works to change public perceptions of recovery, promote effective public policy in Washington, D.C. and in all 50 states, and demonstrate that recovery works. This site provides current news, personal stories, recovery resources, and a number of free publications. http://www.suboxoneassistedtreatment.org/index.html -- Suboxone Assisted Treatment is a subsidiary of Medical Assisted Treatment of America and focuses specifically on education and advocacy about buprenorphine. This site provides patient resources, personal stories, educational information about the medication and treatment process. http://www.methadonesupport.org -- The official site of the Methadone Anonymous (MA) community provides information on Methadone Anonymous meetings, patient resources, online support forums, methadone and pregnancy, and patients recovery stories. http://www.methadone.org -- The National Alliance of Medication Assisted Recovery (NAMA) is an organization that brings together treatment professionals, patients, and the community to advocate for addressing stigma and improving access to quality MAT. This site provides information on how to become a certified advocate, current news, educational materials and publications, and resources for patients. http://www.pfr.samhsa.gov/ -- The SAMHSA Partners for Recovery Initiative provides technical assistance and support to aid in improving the system of care for individuals with substance use disorders and co-occurring mental health disorders. This website provides free resources and information on current projects in different states that are addressing focus areas such as workforce development and reducing stigma. Educational and Professional

http://www.kap.samhsa.gov/documents/catalog.pdf -- This is the 2010 catalog of SAMHSA s publications available for order. The majority of these resources can either be downloaded for free or you may order a hard copy for no charge. http://www.emergingsolutionsinpain.com/ -- Emerging Solutions in Pain (ESP) is an educational initiative developed to address some of today's most critical issues in pain management. These issues involve balancing fundamental rights of patients and clinicians with the challenge of risk containment for opioid misuse, abuse and addiction associated with medical prescribing and use of controlled substances. There are a number of toolkits, case studies, free screening tools and other resources. http://www.ireta.org/ -- The Institute for Research, Education, and Training in Addictions (IRETA) is a 501 (c) (3) organization that works with national, state, and local partners to improve recognition, prevention, treatment, research and policy related to addiction and recovery. This site provides current news and research and a number of educational documents that can be downloaded for free. http://www.ndri.org/ -- National Development and Research Institutes, Inc. (NDRI) is a not-for-profit, tax-exempt non-governmental agency. The primary mission of NDRI is to advance scientific knowledge in the areas of substance abuse, mental health, HIV/AIDS, and other related social and health concerns in order to contribute to the prevention and solution of these social problems. This site provides information on available trainings, current research projects, and related publications. http://naddi.associationdatabase.com/aws/naddi/pt/sp/home_page -- The National Association of Drug Diversion Investigators (NADDI) is a non-profit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of prescription drug diversion. This site provides information on current research and projects and other resources. http://www.suboxone.com/ -- This is the official site for Suboxone by Reckitt Benckiser. The site provides information on how the medication works, the treatment process, information for families, client stories, and links to other resources. http://dpt.samhsa.gov/ -- The Center for Substance Abuse Treatment's Division of Pharmacologic Therapies (DPT) manages the day-to-day regulatory oversight activities necessary to implement new SAMHSA regulations (42 CFR Part 8) on the use of Opioid agonist medications (methadone, LAAM, and Buprenorphine) approved by the Food and Drug Administration (FDA) for addiction treatment. DPT provides a number of resources, free publications, and current news and events.

http://www.aatod.org/ -- The American Association for the Treatment of Opioid Dependence (AATOD) was founded in 1984 to enhance the quality of patient care in treatment programs by promoting the growth and development of comprehensive methadone treatment services throughout the United States. This site provides information about the AATOD conference held every 18 months, available literature and guidelines, and relevant current news. http://www.atforum.com/ -- This website features extensive resources, such as: current and past issues of Addiction Treatment Forum newsletters, special research reports, regularly updated news, and much more. Although many treatment options and healthcare topics of concern are regularly discussed, a primary focus is on methadone maintenance for opioid-addiction treatment. http://www.opiateaddictionrx.info/ -- The International Center for the Advancement of Addiction Treatment/ Baron Edmond de Rothschild Chemical Dependency Institute promotes among medical professionals, the humane treatment of people who are living with opioid addiction, by providing relevant medical, legal and policy information and advocating for change. http://www.pcssmentor.org/ -- The Physician Clinical Support System (PCSS) is a national program that is free and provides information and mentoring on utilizing methadone for treatment of opioid addiction and/or pain and utilizing buprenorphine for treatment of opioid addiction. Health care practitioners can connect with experts in the field, obtain a mentor, and also access a number of free resources. This site provides links to webinars, clinical guidelines, upcoming in-person trainings, and information on relevant legislation and policies. http://international.drugabuse.gov/collaboration/pdfs/methadoneresearchwebg uide.pdf -- The National Institute on Drug Abuse provides this research guide on methadone as a Web-based resource for the international community, NIDA grantees, and others to develop their knowledge and understanding of U.S. methadone maintenance research, learn best practices in methadone treatment and program design and implementation, and have access to approved treatment protocols. http://www.attcnetwork.org/index.asp -- The Addiction Technology Transfer Center (ATTC) network is funded by SAMHSA and provides resources, training, and skill building to addiction treatment professionals. This site provides information on upcoming trainings and events, leadership initiatives, and links to each regional center where you can find further information about their individual projects and trainings Regulations, Standards, and Guidelines

http://www.lrc.ky.gov/kar/908/001/340.htm -- This is a direct link to the Kentucky State Regulations for opioid treatment programs. These are the regulations that all opiate treatment programs must follow in order to open and operate. http://www.access.gpo.gov/nara/cfr/waisidx_05/42cfr8_05.html -- This is a direct link to the Federal Regulations for opioid treatment programs. These are the regulations that all opiate treatment programs must follow in order to open and operate. http://buprenorphine.samhsa.gov/fulllaw.html -- This is the full text of the Drug Addiction Treatment Act of 2000 (DATA 2000), which permits qualified physicians to treat opioid addiction with FDA approved Schedule III, IV, and V narcotic medications. http://www.deadiversion.usdoj.gov/pubs/manuals/narcotic/index.html -- This guideline is provided by The Drug Enforcement Administration (DEA) to assist in the understanding, implementation, and compliance with the controlled substances regulations as they apply to practices in opioid treatment programs. http://buprenorphine.samhsa.gov/bup%20guidelines.pdf -- This SAMHSA Treatment Improvement Protocol (TIP) 40 covers screening, assessment, and diagnosis of opioid dependence and its associated problems; assessment protocols for use in determining when buprenorphine is an appropriate treatment option; referrals to treatment professionals to provide the counseling and participation in self-help programs needed by most patients addicted to heroin or opioid prescription pain medications; detailed clinical protocols for use of buprenorphine in a variety of scenarios; and guidance on co-occurring pain, psychological disorders, or chemical dependency involving more than one substance.